SCHEMBL7670076

SCHEMBL7670076

CCCCn1cnc2c(Oc3cccc(OC)c3)nc(Nc3ccc(F)cc3)nc21

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 3/20 0.47
CCNE1 P24864 3/20 0.47
CDK2 P24941 3/20 0.47
CDK1 P06493 9/20 0.44
KCNH3 Q9ULD8 2/20 0.42
USP2 O75604 3/20 0.41
LMNA P02545 3/20 0.41
CYP1A2 P05177 3/20 0.41
CASP1 P29466 3/20 0.41
CASP7 P55210 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
HBB P68871 1/20 0.41
CLK4 Q9HAZ1 1/20 0.40
CTSL P07711 1/20 0.40
PIK3CA P42336 1/20 0.39
PIK3CG P48736 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7663415 0.90 PDGFRA (0.47) PDGFRACCNE1CDK2CDK1KCNH3
SCHEMBL7358873 0.87 CTSL (0.46) PDGFRACCNE1CDK2CDK1KCNH3
SCHEMBL7661496 0.86 CTSL (0.41) PDGFRACCNE1CDK2CDK1KCNH3
SCHEMBL7362489 0.86 CCNE1 (0.49) PDGFRACCNE1CDK2CDK1KCNH3
SCHEMBL7670599 0.85 CTSL (0.42) PDGFRACCNE1CDK2CDK1KCNH3
SCHEMBL7672226 0.84 CDK1 (0.45) PDGFRACCNE1CDK2CDK1KCNH3
SCHEMBL7363934 0.83 CCNE1 (0.52) PDGFRACCNE1CDK2CDK1CTSL
SCHEMBL7670226 0.82 CDK1 (0.39) PDGFRACCNE1CDK2CDK1KCNH3
SCHEMBL7674300 0.82 CTSL (0.50) PDGFRACCNE1CDK2CDK1CTSL
SCHEMBL7357728 0.81 CTSL (0.43) PDGFRACCNE1CDK2CDK1KCNH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 US claimed
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 US disclosed